MICHELLE JOY RABARA: Open Payments
NPI 1043892250 · SIERRA VISTA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$298 in 16 payments from 10 companies in 2025. Trend: 2023 $115 · 2024 $129 · 2025 $298
Food & beverage: $298
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $69 |
| ABBVIE INC. | 2 | $42 |
| Lilly USA, LLC | 2 | $36 |
| Amgen Inc. | 2 | $34 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $32 |
| Globus Medical, Inc. | 1 | $21 |
| Novo Nordisk Inc | 1 | $18 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
| Exact Sciences Corporation | 1 | $15 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
Products named: VRAYLAR, BREZTRI, EVENITY, CAPLYTA, Senza, MOUNJARO, Rybelsus, XIFAXAN.
Industry payments across AZ — which companies pay providers there.
